GSK announced FDA’s approval of Blenrep in combination with bortezomib and dexamethasone (BVd) for the treatment of adults diagnosed with relapsed or refractory multiple myeloma who received a minimum ...
GSK’s Blenrep receives US FDA approval to treat relapsed/refractory multiple myeloma: London, UK Saturday, October 25, 2025, 11:00 Hrs [IST] GSK plc announced the US Food and Dr ...
Migraine Again on MSN
The Complete Guide to Migraine Relief: What’s New and What’s Still Tried-and-True
There are many effective acute and preventive migraine treatment options available today, including whole new medication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback